Company intelligence / Profile preview

ACX Instruments

Cambridge, England, United Kingdomacxinst.com ↗

Ownership: Private
Development stage: Commercial

Overview

ACX Instruments has developed and commercialized the BOXmini SCP, a fully integrated digital microfluidics-based sample preparation system for single-cell proteomics. The system enables high-throughput, automated sorting and processing of individual cells for proteomic analysis in under 6 hours. It is designed to overcome technical barriers in single-cell sample prep workflows by providing robust data stability, reproducibility, and parallelization capabilities.

Modalities: DeviceDigital microfluidics platform (enabling technology for single-cell proteomics)
Industry: Non-Drug Biotech

Partnerships

No specific major pharmaceutical or biotech partnerships publicly listed as of June 2025. The company expresses openness to collaborations with organizations solving biotech problems.

Beyond the preview

Go deeper on ACX Instruments.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACX Instruments.

Explore the full profile